{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"120"}],"units":"Participants"}],"description":"Number of participants with treatment related grade 2-4 adverse events as defined by CTCAE 3.0","groups":[{"description":"Temozolomide\n\ntemozolomide: Chemotherapy","id":"OG000","title":"Temozolomide"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Time from registration up to 13 months","title":"Safety Profile","type":"SECONDARY","unitOfMeasure":"Participants"}